Pavel Raifeld compensation by year
Innoviva Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $222,000 | $391,458 | $440,000 | $485,000 | $503,333 | $600,000 |
| Bonus | $132,968 | $234,952 | $294,333 | $361,648 | $414,747 | $378,000 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $2,649,982 |
| Option awards | $1,570,000 | $580,330 | $1,044,300 | $0 | $1,775,340 | $1,748,882 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $19,000 | $64,398 | $20,333 | $22,000 | $23,000 | $23,333 |
| Total | $1,943,968 | $1,271,138 | $1,798,966 | $868,648 | $2,716,420 | $5,400,197 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Innoviva, Inc. DEF 14A filed March 24, 2026, accession 0001140361-26-010912, and prior-year filings.
How this page was built: the Innoviva, Inc. filed document, accession 0001140361-26-010912. Every figure is read from that document and cited to the page and table it appears in. Filed March 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 110,436 | $2,207,415 | — |
| RSU | 37,377 | $747,166 | — |
| Option | 56,250 | — | $18.00 |
| Option | 18,750 | — | $16.31 |
| Option | 42,187 | — | $14.88 |
| Option | 84,375 | — | $20.00 |
| Option | 243,750 | — | $17.39 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Innoviva, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
5 Form 4 lines since the FY2025 proxy (filed March 24, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-20 | Tax withholding | — | 1,130 | $21.00 | 284,799 |
| 2026-05-20 | Tax withholding | — | 1,130 | $22.24 | 285,929 |
| 2026-05-15 | Grant or award | — | 1,123 | $0.00 | 287,059 |
| 2026-05-04 | Grant or award | — | 126,646 | $0.00 | 285,936 |
| 2026-05-04 | Grant or award derivative | — | 312,500 | $0.00 | 312,500 |
The 5 most recent of 5 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Innoviva discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control, no termination | $0 | $3,985,045 | $0 | $3,985,045 |
| Involuntary termination without cause | $300,000 | $0 | $0 | $778,961 |
| Change in control and involuntary termination | $300,000 | $3,985,045 | $0 | $4,764,006 |
Per the Potential Payments Upon Termination or Change in Control table in Innoviva, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Innoviva’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Pavel Raifeld · this page | Chief Executive Officer | $5,400,197 |
| Stephen Basso | Chief Financial Officer and President of IST | $2,171,276 |
| Marianne Zhen | Chief Accounting Officer | $1,082,859 |
Board service
Innoviva board · FY2024How this board is paid
Company policy: Innoviva pays directors a $50,000 cash retainer and $225,000 in RSUs/Options. As stated in Innoviva's FY2024 proxy.
The full Innoviva compensation record
free company briefThis page is one person within Innoviva's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Innoviva proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Innoviva's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Innoviva's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.